Net profit of Alembic declined 41.73% to Rs 3.24 crore in the quarter ended December 2018 as against Rs 5.56 crore during the previous quarter ended December 2017. Sales declined 18.78% to Rs 24.31 crore in the quarter ended December 2018 as against Rs 29.93 crore during the previous quarter ended December 2017.

Powered by Capital Market - Live News

Alembic will hold a meeting of the Board of Directors of the Company on 30 January 2019.

Powered by Capital Market - Live News

Alembic Ltd rose 11.14% today to trade at Rs 50.4. The S&P BSE Healthcare index is up 0.25% to quote at 13909.98. The index is down 2.28 % over last one month. Among the other constituents of the index, Alembic Pharmaceuticals Ltd increased 3.98% and Bliss GVS Pharma Ltd added 3% on the day. The S&P BSE Healthcare index went down 2.72 % over last one year compared to the 7.48% surge in benchmark SENSEX.

Alembic Ltd has added 19.29% over last one month compared to 2.28% fall in S&P BSE Healthcare index and 2.34% rise in the SENSEX. On the BSE, 71724 shares were traded in the counter so far compared with average daily volumes of 46702 shares in the past one month. The stock hit a record high of Rs 72 on 24 Jan 2018. The stock hit a 52-week low of Rs 35.75 on 24 Jul 2018.

Powered by Capital Market - Live News

Net profit of Alembic rose 4.00% to Rs 29.35 crore in the quarter ended September 2018 as against Rs 28.22 crore during the previous quarter ended September 2017. Sales rose 3.13% to Rs 33.56 crore in the quarter ended September 2018 as against Rs 32.54 crore during the previous quarter ended September 2017.

Powered by Capital Market - Live News